⌘K

Login Start Free

Home/Filings/4/0001562180-20-002136

4//SEC Filing

Das Asha 4

Accession 0001562180-20-002136

CIK 0000835887other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:15 PM ET

Size

5.4 KB

Accession

0001562180-20-002136

Insider Transaction Report

Form 4

Period: 2020-03-02

PROGENICS PHARMACEUTICALS INCPGNX

Chief Medical Officer

Transactions

Award
Non-Qualified Stock Option (Right to Buy)
2020-03-02+82,214→ 82,214 total
Exercise: $4.77Exp: 2030-03-02→ Common Stock (82,214 underlying)

Footnotes (1)

[F1]3yr 33% On Vest beginning on 02-Mar-2020

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1

filerCIK 0001701647

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 4:15 PM ET
Size: 5.4 KB

View on SEC.gov